• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TAH
Click for more information
0.00% $2.20

Third Age Health Services Limited Ordinary Shares

watchlist Created with Sketch. Add to my watchlist
Healthcare

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
TAH
Ann: Notice of on-market share buyback 		29/08/24 0 68
29/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  68 
TAH
Ann: Notice of on-market share buyback 		28/08/24 0 40
28/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  40 
TAH
Ann: Results of TAH Annual Shareholder Meeting 2024 		26/08/24 0 57
26/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  57 
TAH
Ann: 2024 TAH Annual Shareholders Meeting Prepared Address 		23/08/24 0 63
23/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  63 
TAH
Ann: Third Age Health announces on-market share buyback 		19/08/24 0 67
19/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  67 
TAH
Ann: Third Age Health - Interim Dividend Q1 FY25 		26/07/24 0 63
26/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  63 
TAH
Ann: Third Age Health reports record Q1 FY25 		26/07/24 0 82
26/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  82 
TAH
Ann: Third Age Health 2024 AGM 		26/07/24 0 74
26/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  74 

See All Discussions arrow Created with Sketch.

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
(20min delay)
Last
$2.20 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
$2.20 $2.20 $2.20 $145 66

Buyers (Bids)

No. Vol. Price($)
0 221 $2.15
 

Sellers (Offers)

Price($) Vol. No.
$2.20 3986 0
Last trade - 05.59am 20/09/2024 (20 minute delay) ?
TAH (NZSX) Chart

Top Stories

Develop Global appoints GR to get Woodlawn copper-zinc plant online mid-2025

Develop shares jumped just over 4% in lunchtime trades on Friday as the company sees mid-2025 Woodlawn start.
Harvey Norman hit with a second class action – and shareholders, once again, don't care Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
Tennant Minerals clocks high-grade gold, copper hits at Bluebird in the NT Tennant Minerals has unveiled the results of its latest drill campaign at its Bluebird project, posting "high-grade" copper and gold hits.
Catalina Resources kicks off aircore drilling at Laverton project on the hunt for gold, REEs Catalina Resources has confirmed its latest drill run has kicked off on-site its Laverton Project in Western Australia's Northern Goldfields.
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.